Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Insider Trading: Thomas E. Claugus’ GMT Capital Bought More $ENTG

Thomas E. Claugus’ GMT Capital bought 111,900 shares in Entegris Inc. (ENTG) on October 24th. GMT Capital is ENTG’s largest insider and stakeholder. According to the 13G filing, after GMT Capital made the insider purchase of 111,900 shares at about $8.20 on October 24th, the firm had 13.88 million ENTG shares in its position, corresponding to a 10.3% passive stake ownership. In the second quarter, GMT Capital reported 11.48 million shares in ENTG. ENTG has returned 10% year to date. On October 26th, the stock is closed at $8.56.

Entegris Inc (NASDAQ:ENTG)

Per Insider Monkey’s hedge fund tracking list, eleven hedge funds had ENTG in their portfolios in the second quarter, and GMT Capital took the largest portion. Richard Chilton’s Chilton Investment Company had 8.51 million shares. These two had a bigger stake in ENTG than did the remaining nine hedge funds combined in the second quarter.

GMT Capital is a private investment company, targeting long-term absolute returns in Basic Materials, Technology, Services, Financial, Consumer Goods and some other sectors. The company had a 13F portfolio of $4.4 billion in the second quarter. Mr. Thomas E. Claugus is the Founder and President at GMT Capital. Before he found GMT Capital in 1990, he acted as a manager for Europe of the polymers division of Rohm and Haas.

Entegris, Inc. is a global developer, manufacturer and supplier. The company specializes in products and materials used in processing and manufacturing in the semiconductor and other high-technology industries. The company operates three segments: contamination control solutions segment, microenvironments segment, and its specialty materials segment. In October 2011, the company opened a new manufacturing and research facility in Hsinchu City, Taiwan. The company was founded in 1966 and is based in Billerica, Massachusetts.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!